China Captopril manufacturers and suppliers |CPF

Captopril

Description:

API Nomen	Indicium	Specification	US DMF	EU DMF	CEP
Captopril	Hypertension	USP/EP

Mitte ad nos inscriptio

Product Detail

Product Tags

Product SINGULA

Descriptio

Captopril (SQ-14534) est potens, auctor inhibitor angiotensin-conversionis enzyme (ACE).

In vitro

Captopril (SQ-14534) ostensum est, similes morbiditatis et mortalitatis beneficia erga aegros diureticos et beta-blockersos in hypertensivis habere.Captopril (SQ-14534) ostensum est progressionem nephropathiae diabeticae morari, et enalapril et lisinoprilis impedire progressionem nephropathiae in aegris normoalbuminicis cum diabete[1].Ratio aequimolaris cis et trans status Captoprilis (SQ-14534) in solutione existit et enzyme solum eligat statum trans- inhibitoris, qui exhibet complementarium architecturae et stereo- electronicae cum suo substrato ligaturae sulcus[2].

MCE independenter subtilitatem horum methodorum non confirmavit.Tantum referendi sunt.

Orci iudicio

NCT Number	Sponsor	Conditio	Satus Date	Phase
NCT03179163	Penn State University\|National Heart, Lung, and Sanguinis Institutum (NHLBI)	Hypertension, Essentiale	Die 20 Iulii 2016	Phase 1\|Phase 2
NCT03660293	Tanta University	Diabetes Mellitus, Typus 1	Aprilis 1, 2017	Non pertinet
NCT03147092	Centro Neurológico de Pesquisa e Reabiitaci, Brazil	Hypertension\|Impressio sanguinis	Februarii 1, 2018	Mane Phase 1
NCT00252317	Rigshospitalet, Denmark	Aorta Stenosis	Novembris 2005	Phase 4
NCT02217852	West Sinis Hospitalis	Hypertension	August 2014	Phase 4
NCT01626469	Brigham ac Women's Hospitalis	Typus 2 Diabetes Mellitus	May 2012	Phase 1\|Phase 2
NCT00391846	AstraZeneca	Cordis Deficio\|Ventricularis Praesent, Left	Octobris 2006	Phase 4
NCT00240656	Hebei Medical University	Hypertension, Pulmonarium	Octobris 2005	Phase 1
NCT00086723	Northwestern University\|National Cancer Institute (NCI)	Adultus Solidus Tumor, Protocollum Imprimis	Iulii 2003	Phase 1\|Phase 2
NCT00663949	Scirasium University of Sciences Medical	Diabetic Nephropathia	Februarii 2006	Phase 2\|Phase 3
NCT01437371	University Hospital, Clermont-Ferrand\|Servier\|LivaNova	Cor defectum	August 2011	Phase 3
NCT04288700	Ain Shams University	Infantile Hemangioma	October 1, 2019	Phase 4
NCT00223717	Vanderbilt University\|Vanderbilt University Medical Center	Hypertension	Ianuarii 2001	Phase 1
NCT02770378	University of Ulm	Glioblastoma	November 2016	Phase 1\|Phase 2
NCT01761916	Instituto Materno Infantil Fernando Figueira Prof	Preeclampsia	Ianuarii 2013	Phase 4
NCT01545479	Instituto de Cardiologia do Rio Grande do Sul	Morbus renalis	Ianuarii 2010	Phase 4
NCT00935805	Hospital de Clinicas de Porto Alegre\|Conselho Nacional de Desenvolvimento Científico e Tecnológico	Diabetes Mellitus \|	Iulii 2006
NCT00742040	Hospitale pro infirmis Liberi	Morbus cordis	August 2008	Phase 2
NCT03613506	Wuhan University	Radiotherapy Side Effectus \| Sumens Captopril	die 25 Octobris 2018	Phase 2
NCT00004230	Northwestern University\|National Cancer Institute (NCI)	Cancer	Octobris 1999	Phase 3
NCT00660309	Novartis	Typus 2 Diabetes Mellitus	Aprilis 2008	Phase 4
NCT00292162	NHS Maiora Glasguensis et Clyde	Chronica Cordis Deficio\|Atrial Fibrillation	Ianuarii 2007	Non pertinet
NCT01271478	Coordinación de Investigación en Salud, Mexico	Inflammatio\|Finis-scaena Renal Disease	August 2009	Phase 4
NCT04193137	Chongqing University	Primarius Aldosteronismus	November 30, 2019
NCT00155064	National Taiwan University Hospitalis	Hyperaldosteronism	Iulii 2002	Phase 4
NCT01292694	Vanderbilt University\|Vanderbilt University Medical Center	Hypertension\|Pura autonomica culpa\|Multiplex Ratio Atrophy	Martii 2011	Phase 1
NCT00917345	National Taiwan University Hospital\|Novartis	Primarius Aldosteronismus	Ianuarii 2008
NCT00077064	Radiation Therapy Oncology Group\|National Cancer Institute (NCI)\|NRG Oncology	Lung Cancer\|Pulmonary Complications\|Radiation Fibrosis	Iunii 2003	Phase 2